<VariationArchive RecordType="classified" VariationID="16962" VariationName="NM_002449.5(MSX2):c.475_480del (p.Arg159_Lys160del)" VariationType="Deletion" Accession="VCV000016962" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32001" VariationID="16962">
      <GeneList>
        <Gene Symbol="MSX2" FullName="msh homeobox 2" GeneID="4488" HGNC_ID="HGNC:7392" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="174724582" stop="174730896" display_start="174724582" display_stop="174730896" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="174151574" stop="174157901" display_start="174151574" display_stop="174157901" Strand="+" />
          </Location>
          <OMIM>123101</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSX2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSX2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002449.5(MSX2):c.475_480del (p.Arg159_Lys160del)</Name>
      <CanonicalSPDI>NC_000005.10:174729251:AGCGCAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q35.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="174729252" stop="174729257" display_start="174729252" display_stop="174729257" variantLength="6" positionVCF="174729251" referenceAlleleVCF="GAGCGCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="174156255" stop="174156260" display_start="174156255" display_stop="174156260" variantLength="6" positionVCF="174156254" referenceAlleleVCF="GAGCGCA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.174729254_174729259del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.174729254_174729259del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.174156257_174156262del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.174156257_174156262del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008124.1" sequenceAccession="NG_008124" sequenceVersion="1" change="g.9683_9688del">
            <Expression>NG_008124.1:g.9683_9688del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363626.2" sequenceAccession="NM_001363626" sequenceVersion="2" change="c.*99_*104del">
            <Expression>NM_001363626.2:c.*99_*104del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002449.5" sequenceAccession="NM_002449" sequenceVersion="5" change="c.475_480del" MANESelect="true">
            <Expression>NM_002449.5:c.475_480del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002440.2" sequenceAccession="NP_002440" sequenceVersion="2" change="p.Arg159_Lys160del">
            <Expression>NP_002440.2:p.Arg159_Lys160del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="123101.0002" DB="OMIM" />
        <XRef Type="rs" ID="2113498725" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002449.5(MSX2):c.475_480del (p.Arg159_Lys160del) AND Parietal foramina 1" Accession="RCV000018475" Version="28">
        <ClassifiedConditionList TraitSetID="5588">
          <ClassifiedCondition DB="MedGen" ID="C1868599">Parietal foramina 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10742103</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5588" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8759" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parietal foramina 1</ElementValue>
                <XRef ID="MONDO:0008197" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FORAMINA PARIETALIA PERMAGNA</ElementValue>
                <XRef Type="MIM" ID="168500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARIETAL FORAMINA, SYMMETRIC</ElementValue>
                <XRef Type="MIM" ID="168500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PFM1</ElementValue>
                <XRef Type="MIM" ID="168500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PFM</ElementValue>
                <XRef Type="MIM" ID="168500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPP</ElementValue>
                <XRef Type="MIM" ID="168500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Enlarged parietal foramina are characteristic symmetric, paired radiolucencies of the parietal bones, located close to the intersection of the sagittal and lambdoid sutures, caused by deficient ossification around the parietal notch, which is normally obliterated by the fifth month of fetal development. Enlarged parietal foramina are usually asymptomatic. Meningeal, cortical, and vascular malformations of the posterior fossa occasionally accompany the bone defects and may predispose to epilepsy. In a minority of individuals, headaches, vomiting, or intense local pain are sometimes associated with the defects, especially on application of mild pressure to the unprotected cerebral cortex.</Attribute>
                <XRef ID="NBK1128" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18051" />
                <XRef ID="18051" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301307</ID>
                <ID Source="BookShelf">NBK1128</ID>
              </Citation>
              <XRef ID="60015" DB="Orphanet" />
              <XRef ID="C1868599" DB="MedGen" />
              <XRef ID="MONDO:0008197" DB="MONDO" />
              <XRef Type="MIM" ID="168500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38757" SubmissionDate="2016-05-23" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="123101.0002_PARIETAL FORAMINA 1" title="MSX2, 6-BP DEL, NT475_PARIETAL FORAMINA 1" />
        <ClinVarAccession Accession="SCV000038757" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with autosomal dominant enlarged parietal foramina (PFM1; 168500), Wilkie et al. (2000) identified deletion of 6 nucleotides (475-480) of the MSX2 gene resulting in the deletion of 2 amino acids, arginine and lysine, from codons 159 and 160. This mutation occurs in helix 1. Mouse protein with the same mutation showed DNA-binding affinity reduced to 3% that of wildtype.</Attribute>
              <Citation>
                <ID Source="PubMed">10742103</ID>
              </Citation>
              <XRef DB="OMIM" ID="168500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSX2" />
          </GeneList>
          <Name>MSX2, 6-BP DEL, NT475</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, NT475</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="123101.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARIETAL FORAMINA 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38757" TraitType="Disease" MappingType="Name" MappingValue="PARIETAL FORAMINA 1" MappingRef="Preferred">
        <MedGen CUI="C1868599" Name="Parietal foramina 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

